The pain drug market has many products, but there’s still a need for pills with better properties, such as avoiding addiction. Eli Lilly sees potential in the non-opioid pain drug research from Confo Therapeutics…
Continue Reading
Remote patient monitoring (RPM) technology saw a significant rise in adoption during the pandemic, but it hasn’t gone completely mainstream, according to a new report from analytics company Definitive Healthcare.
Just a quarter of healthcare…
MorphoSys, a company whose research has yielded programs placed with big pharmaceutical companies and upstart biotechs, is stopping all preclinical work to focus on cancer, particularly a late-stage drug candidate it acquired in a…
Continue Reading
Multinational pharmaceutical and biotech company Pfizer and AI-powered data company Tempus announced a multi-year strategic alliance to utilize AI and machine learning to inform drug discovery and development in oncology. Pfizer will leverage Tempus’ library…
Continue Reading
R-Zero’s UV-C Technology Improves Indoor Air Quality for Millions of People; Reduces Reliance on HVAC Systems and Chemicals that Harm Environment
R-Zero, a global leader in healthy buildings and green buildings, today announced it has…
The following is a guest article by Tamara Badza is a manager at Inviggo.
The Internet of Things (IoT) has transformed the healthcare industry, allowing for the collection and analysis of vast amounts of data…
Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of its second startup, DenovAI.DenovAI will develop an AI-enabled computational biophysics platform that can discover potential antibodies…
Continue Reading
Researchers at the Harvard Wyss Institute are collaborating with a biotechnology company called Gameto to develop human ovarian organoids that will allow the study of reproductive and other health issues using tissues that closely…
Continue Reading
Aptinyx’s approach of treating neurological disorders by targeting a key receptor in the brain has fallen short again, this time in Parkinson’s disease. With its third clinical trial failure in less than a year,…
Continue Reading
The Centers for Disease Control and Prevention recently issued an advisory about a bacteria called shigella. The agency is warning the public about shigella because of a nationwide increase in infections resulting from drug-resistant…
Continue Reading
